Literature DB >> 16487302

Secretion of serine peptidase by a clinical strain of Candida albicans: influence of growth conditions and cleavage of human serum proteins and extracellular matrix components.

André Luis Souza dos Santos1, Isabela Miller de Carvalho, Bianca Alcântara da Silva, Maristela Barbosa Portela, Celuta Sales Alviano, Rosangela Maria de Araújo Soares.   

Abstract

Candida albicans expresses a vast number of hydrolytic enzymes, playing roles in several phases of yeast-host interactions. Here, we identified two novel extracellular peptidase classes in C. albicans. Using gelatin-sodium dodecyl sulfate polyacrylamide gel electrophoresis two gelatinolytic activities were detected at physiological pH: a 60-kDa metallopeptidase, completely blocked by 1,10-phenanthroline, and a 50-kDa serine peptidase inhibited by phenylmethylsulfonyl fluoride. In an effort to establish a probable functional implication for these novel peptidase classes, we demonstrated that the 50-kDa secretory serine peptidase was active over a broad pH range (5.0-7.2) and was capable to hydrolyze some soluble human serum proteins and extracellular matrix components. Conversely, when this isolate was grown in yeast carbon base supplemented with bovine serum albumin, a secretory aspartyl peptidase activity was measured, instead of metallo- and serine peptidases, suggesting that distinct medium composition induces different expression of released peptidases in C. albicans. Additionally, we showed by quantitative proteolytic measurement, flow cytometry and immunoblotting assays that the brain heart infusion medium might repress the Sap1-3 production. Collectively, our results showed for the first time the capability of an extracellular proteolytic enzyme other than aspartic-type peptidases to cleave a broad spectrum of relevant host proteinaceous substrates by the human pathogen C. albicans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487302     DOI: 10.1111/j.1574-695X.2005.00023.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  8 in total

1.  Protease expression by microorganisms and its relevance to crucial physiological/pathological events.

Authors:  André Luis Souza Dos Santos
Journal:  World J Biol Chem       Date:  2011-03-26

2.  HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos.

Authors:  André Luis Souza Dos Santos
Journal:  World J Biol Chem       Date:  2010-02-26

3.  Proteins and peptidases from conidia and mycelia of Scedosporium apiospermum strain HLPB.

Authors:  Martha Machado Pereira; Bianca Alcântara Silva; Marcia Ribeiro Pinto; Eliana Barreto-Bergter; André Luis Souza dos Santos
Journal:  Mycopathologia       Date:  2008-08-23       Impact factor: 2.574

4.  Relevant and selective activity of Pancratium illyricum L. against Candida albicans clinical isolates: a combined effect on yeast growth and virulence.

Authors:  Francesca Bonvicini; Fabiana Antognoni; Carmelina Iannello; Andrea Maxia; Ferruccio Poli; Giovanna Angela Gentilomi
Journal:  BMC Complement Altern Med       Date:  2014-10-23       Impact factor: 3.659

5.  Fungal lifestyle reflected in serine protease repertoire.

Authors:  Anna Muszewska; Marta M Stepniewska-Dziubinska; Kamil Steczkiewicz; Julia Pawlowska; Agata Dziedzic; Krzysztof Ginalski
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

6.  Disruption of a C69-Family Cysteine Dipeptidase Gene Enhances Heat Shock and UV-B Tolerances in Metarhizium acridum.

Authors:  Juan Li; Mei Guo; Yueqing Cao; Yuxian Xia
Journal:  Front Microbiol       Date:  2020-05-05       Impact factor: 5.640

7.  The Threat Called Candida haemulonii Species Complex in Rio de Janeiro State, Brazil: Focus on Antifungal Resistance and Virulence Attributes.

Authors:  Lívia S Ramos; Maria Helena G Figueiredo-Carvalho; Laura N Silva; Nahyara L M Siqueira; Joice C Lima; Samuel S Oliveira; Rodrigo Almeida-Paes; Rosely M Zancopé-Oliveira; Fabio S Azevedo; Adriana L P Ferreira; Marta H Branquinha; André L S Santos
Journal:  J Fungi (Basel)       Date:  2022-05-27

8.  Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans-In Silico, In Vitro and In Vivo Approaches.

Authors:  André L S Santos; Lys A Braga-Silva; Diego S Gonçalves; Lívia S Ramos; Simone S C Oliveira; Lucieri O P Souza; Vanessa S Oliveira; Roberto D Lins; Marcia R Pinto; Julian E Muñoz; Carlos P Taborda; Marta H Branquinha
Journal:  J Fungi (Basel)       Date:  2021-05-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.